Management

Dr. von Roemling is Senior Vice President of Clinical Development at Curis. Prior to joining Curis, he served as Global Head of Research and Development at Huya Bioscience International. Previously, Dr. von Roemling held various leadership roles in oncology research and clinical development at EMD-Serono, Daiichi Sankyo, Fresenius Group, Schering AG/Berlex, Boehringer Ingelheim, Sanofi and Sterling-Winthrop. He has directed, co-directed and supported over 25 small molecule and biologics development programs. Dr. von Roemling holds an M.D. from Goethe University of Frankfurt.